Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2025-12-30 @ 6:26 AM
Study NCT ID:
NCT01882803
Status:
COMPLETED
Last Update Posted:
2023-09-07
First Post:
2013-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Duvelisib in Participants With Refractory Indolent Non-Hodgkin Lymphoma
Sponsor:
SecuraBio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-18
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-31
First Submit QC Date:
None
Study First Post Date:
2013-06-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-10-23
Results First Submit QC Date:
None
Results First Post Date:
2018-11-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-05-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-09-05
Last Update Post Date:
2023-09-07
Last Update Post Date Type:
ACTUAL